5 news items
MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy
INCY
JAZZ
MIRA
23 Jul 24
THIO is not just another cancer drug; it's a telomere-targeting agent that induces profound biological responses in cancer cells. It damages telomeric
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
AEON
AES
AGRI
15 Jul 24
Nunes issued the following statement in response to the attempted assassination of President Donald J. Trump, “I offer my deepest sympathies
MIRA Pharmaceuticals' Preclinical Study Shows MIRA-55's Enhanced Efficacy Over THC in Treating Anxiety and Cognitive Decline
MIRA
15 Jul 24
activity as the concentration increases, indicating the potential for greater effectiveness in activating key cannabinoid receptors responsible for its
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
MIRA
15 Jul 24
cannabinoid receptors responsible for its therapeutic effects. These results confirmed MIRA's belief that MIRA-55 could potentially provide stronger and more
Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance
MIRA
29 May 24
at high doses), MIRA55 demonstrates a monophasic dose-response in pre-clinical models, indicating a more stable and consistent anti-anxiety effect
- Prev
- 1
- Next